Rosiglitazone: FDA adverse event reports
104,293 FDA FAERS reports mention Rosiglitazone. 89,471 reports have a serious outcome flag.
Reported reactions
- Myocardial Infarction: 34,847 reports
- Cardiac Failure Congestive: 26,799 reports
- Cerebrovascular Accident: 15,368 reports
- Coronary Artery Disease: 9,656 reports
- Cardiac Disorder: 6,966 reports
- Death: 5,620 reports
- Acute Myocardial Infarction: 3,476 reports
- Injury: 2,915 reports
- Blood Glucose Increased: 2,881 reports
- Chest Pain: 2,806 reports
- Cardiovascular Disorder: 2,579 reports
- Dyspnoea: 2,408 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.